Terlipressin Market

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

What is Terlipressin?
Terlipressin is used as a vasoactive drug in the management of hypotension, hepatorenal syndrome and for the treatment of bleeding oesophageal varices. It is similar to vasopressin, is a prohormone of lysine‐vasopressin. It is the drug of choice for the treatment of hepatorenal syndrome and mostly used for the same.

Global Terlipressin Market Outlook
The increasing occurrence of liver and kidney deceases with impaired kidney function that is hepatorenal syndrome is stimulating the growth of the terlipressin market. The prevalence of the hepatorenal syndrome is unidentified but is predicted to occur in approximately 8-10 percent of individuals. Terlipressin delivers longer biological activity and comparatively lesser side effects than vasopressin and is effective in controlling AVB. It reduces failure to control bleeding and mortality, is the first choice for pharmacological therapy when available.
The use of terlipressin as a drug has been proved to be safe, with minimal side effects that usually disappear after dose reduction, and results in an improved outcome in patients with hepatorenal syndrome. It is approved for use in Europe for patients with hepatorenal syndrome and trials to get it approved in the US are in progress. During findings, it has been found that terlipressin is studied the most for individuals with the hepatorenal syndrome and results have shown improved renal function in affected individuals than alternatives. Availability issues are restraining the growth of the terlipressin market. At present, terlipressin is not available in the United States and Canada. But is available in New Zealand, Australia, much of Europe, India & UAE and Pakistan. Easy availability of alternatives such as somatostatin, octreotide, and vapreotide restrains the growth of the market.

Global Terlipressin Market Competitive Landscape
The "Global Terlipressin Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such EVER Pharma, Hybio Pharmaceutical, Sun Pharmaceutical Industries Ltd., Shanghai Soho-Yiming Pharmaceuticals, Xi ‘an langene biological technology, SGPharma, Maya Biotech and Hangzhou Huadi Group. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.

1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions


3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5.1. Overview
5.2. Injection
5.3. Other

6.1. Overview
6.2. ≥98%
6.3. <98%

7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa

8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9.1. EVER Pharma
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Hybio Pharmaceutical
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Sun Pharmaceutical Industries Ltd.
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. Shanghai Soho-Yiming Pharmaceuticals
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Xi ‘an langene biological technology
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
9.6. SGPharma
9.6.1. Overview
9.6.2. Financial Performance
9.6.3. Product Outlook
9.6.4. Key Developments
9.7. Maya Biotech
9.7.1. Overview
9.7.2. Financial Performance
9.7.3. Product Outlook
9.7.4. Key Developments

9.8. Hangzhou Huadi Group
9.8.1. Overview
9.8.2. Financial Performance
9.8.3. Product Outlook
9.8.4. Key Developments

10. Appendix
10.1. Related Reports

Healthcare and Pharmaceuticals

Global Terlipressin Market Analysis 2015-2019 and Forecast 2020-2025

  Price : US$ 2,980   Date : Feb 2020
  Category : Healthcare and Pharmaceuticals   Pages : 87
Healthcare and Pharmaceuticals

Global Terlipressin Market Research Report 2020-2024

  Price : US$ 2,850   Date : Dec 2019
  Category : Healthcare and Pharmaceuticals   Pages : 161
Healthcare and Pharmaceuticals

2019 Europe Terlipressin Acetate Industry Report

  Price : US$ 2,600   Date : Nov 2017
  Category : Healthcare and Pharmaceuticals   Pages : 115
Healthcare and Pharmaceuticals

2019 India Terlipressin Acetate Industry Report

  Price : US$ 2,600   Date : Nov 2017
  Category : Healthcare and Pharmaceuticals   Pages : 112

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.


Asia Pacific Intelligence Center (India):
Worldwide Market Reports 203, 2nd Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.


Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection


© 2020 Worldwide Market Reports. All rights reserved